ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis NLRP3 Inflammasome Activation Is Linked to Brain Metastasis in Patients with Triple-Negative Breast Cancer.

Gamma Knife Market Holds a Worth of US$ 343.1 Mn as of 2023, and by 2033, it is Estimated to Reach a Revenue of US$ 600 Mn at CAGR of 5.7% During Forecast Period of 2023-33 | Future Market Insights, Inc. NEWARK, Del, Dec. 26, 2022 (GLOBE NEWSWIRE) -- The global gamma knife market is valued at US$ 343.1 million as of 2023. The market is expected to grow at a CAGR of 5.7% during the forecast period,...

Brain Metastasis Therapeutic Market In North America Is Expected To Account For Major Revenue Share Covering COVID-19 Impact: Acumen Research And Consulting LOS ANGELES, June 03, 2021 (GLOBE NEWSWIRE) -- Brain metastasis occur when cancer cells spread from their original site to the brain. As the metastatic brain tumors grow, they create pressure on and...

Global Gamma Knife Market to surpass US$ 294.5 million by 2027, Says Coherent Market Insights (CMI) SEATTLE, June 03, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global gamma knife market is estimated to be valued at US$ 215.8 million in 2020 and is expected to exhibit a...